NEO
NeoGenomics, Inc.
NEO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
NEO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Weak |
NEO's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
NEO PE Valuation
NEO has no meaningful PE right now: it lost money over the past year.
NEO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for NEO, with profitability improving. However, they disagree widely on these estimates.
NEO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.29 | — |
| Q3 2026 | -$0.25 | +$0.63 |
| Q2 2026 | -$0.40 | +$0.41 |
| Q1 2026 | -$0.77 | -$0.16 |
| Q4 2025 | -$0.84 | -$0.22 |
| Q3 2025 | -$0.88 | -$0.27 |
| Q2 2025 | -$0.81 | -$0.19 |
| Q1 2025 | -$0.61 | +$0.05 |
| Q4 2024 | -$0.62 | +$0.08 |
NEO is still losing money, but far less than before: $0.25 per share over the past year, against $1.28 at its worst in late 2022.
NEO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $209.3M | +11% |
| Q2 2026 | $201.7M | +11% |
| Q1 2026 | $186.7M | +11% |
| Q4 2025 | $190.2M | +11% |
| Q3 2025 | $187.8M | +12% |
| Q2 2025 | $181.3M | +10% |
| Q1 2025 | $168M | +7.5% |
| Q4 2024 | $172M | +11% |
NEO's revenue has grown year over year for 19 quarters in a row: $209M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | +11 points |
| Q2 2026 | -4.8% | +21 points |
| Q1 2026 | -9.8% | +6.8 points |
| Q4 2025 | -7% | +3.6 points |
| Q3 2025 | -14% | -1.8 points |
| Q2 2025 | -26% | -13 points |
| Q1 2025 | -17% | +3 points |
| Q4 2024 | -11% | +1.2 points |
NEO's operating margin was −3.8% last quarter, up 11 points from the same quarter a year ago.
NEO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20.7M | -3724% |
| Q2 2026 | $11.7M | -16% |
| Q1 2026 | -$13.1M | +$16.7M |
| Q4 2025 | -$6.5M | -$4.7M |
| Q3 2025 | $570K | +$2.1M |
| Q2 2025 | $14M | +1621% |
| Q1 2025 | -$29.8M | +$1.7M |
| Q4 2024 | -$1.8M | -117% |
NEO has burned cash in most quarters: −$29M over the past year, against −$17M the year before.
NEO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -2.2M shares |
| 1 year | +0.1% | +172K shares |
| 3 years | +2.3% | +2.9M shares |
| 5 years | +4.9% | +6M shares |
| Available history | +19% | +20.8M shares |
NEO has 129M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
NEO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 14.9x | High |
| Q2 2021 | 14.7x | High |
| Q1 2021 | -6.3x | Net Cash |
| Q4 2020 | -2.7x | Net Cash |
| Q3 2020 | -4.0x | Net Cash |
| Q2 2020 | -9.4x | Net Cash |
| Q1 2020 | 0.5x | Very low |
| Q4 2019 | -1.6x | Net Cash |
NEO's net debt is about 15 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NEO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 38.7 | Neutral |
NEO's weekly RSI is 56 (neutral) and its Stochastic is 39 (neutral).
NEO PE vs Healthcare Sector
| Metric | NEO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
NEO has no meaningful PE right now: it lost money over the past year.
NEO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 4.2% below |
| 20 week MA | $16.7 | 0.8% below |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $11.3 | 46% above |
| 200 week MA | $13.4 | 24% above |
NEO has slipped below its 8- and 20-week averages, though it's still 24% above its 200-week average.
NEO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.8 | $55.4 | +86% |
| 2021 | $55.4 | $34.3 | -38% |
| 2022 | $34.3 | $9.17 | -73% |
| 2023 | $9.17 | $16.2 | +76% |
| 2024 | $16.2 | $16.8 | +4% |
| 2025 | $16.8 | $12.3 | -27% |
| 2026 YTD | $12.3 | $16.5 | +35% |
NEO is up 35% so far in 2026, after finishing lower in three of the previous six years.